Oliman, Jenny .

HRN: 23-06-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
CEFTRIAXONE 1G (VIAL)
05/20/2023
05/26/2023
IVT
320mg
Q12
Pcap C
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: